Douglas Conrad
Impact in
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
-
- Cystic Fibrosis Research Advances
Papers in
-
- Cystic Fibrosis Research Advances 38
- Neonatal Respiratory Health Research 10
- Inhalation and Respiratory Drug Delivery 7
- Tracheal and airway disorders 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
-
- Gut microbiota and health 9
- Bacterial biofilms and quorum sensing 5
- Co-authors
- Forest Rohwer (16 shared papers)Yan Wei Lim (12 shared papers)Elliott Sigal (4 shared papers)Robert Schmieder (6 shared papers)Mike Furlan (6 shared papers)John S. Welch (1 shared paper)Colin Funk (1 shared paper)Carolyn Kelly (1 shared paper)
- Journals
- Journal of Cystic Fibrosis (8 papers)PLoS ONE (5 papers)The ISME Journal (4 papers)American Journal of Respiratory and Critical Care Medicine (3 papers)mBio (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Douglas Conrad
69 papers receiving 3.7k citations
Douglas Conrad's Hit Papers
Peers
Comparison fields: 5 of 140
- Biochemistry 286
- Pulmonary and Respiratory Medicine 1.1k
- Immunology 580
- Molecular Medicine 125
- Molecular Biology 1.7k
Countries citing papers authored by Douglas Conrad
This map shows the geographic impact of Douglas Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Conrad more than expected).
Fields of papers citing papers by Douglas Conrad
This network shows the impact of papers produced by Douglas Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Conrad. The network helps show where Douglas Conrad may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas Conrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase Hit paper breakdown → | 1999 | 752 |
| 2 | 1992 | 337 | |
| 3 | 2009 | 323 | |
| 4 | 2002 | 136 | |
| 5 | 2011 | 135 | |
| 6 | 2012 | 121 | |
| 7 | 2001 | 120 | |
| 8 | 2011 | 118 | |
| 9 | 1991 | 106 | |
| 10 | 2013 | 106 | |
| 11 | 2014 | 93 | |
| 12 | 2014 | 91 | |
| 13 | 2017 | 86 | |
| 14 | 1999 | 80 | |
| 15 | 2012 | 77 | |
| 16 | 2015 | 74 | |
| 17 | 2014 | 74 | |
| 18 | 1995 | 66 | |
| 19 | 2016 | 63 | |
| 20 | 2015 | 55 |
About Douglas Conrad
Douglas Conrad is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology, Physiology and Ecology, having authored 72 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (38 papers), Neonatal Respiratory Health Research (10 papers), Gut microbiota and health (9 papers), Inhalation and Respiratory Drug Delivery (7 papers), Bacterial biofilms and quorum sensing (5 papers), Tracheal and airway disorders (5 papers), Asthma and respiratory diseases (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). The work is most often cited by research in Biochemistry (286 citations), Pulmonary and Respiratory Medicine (1.1k citations), Immunology (580 citations), Molecular Medicine (125 citations) and Molecular Biology (1.7k citations). Douglas Conrad has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Forest Rohwer, Yan Wei Lim, Elliott Sigal, Robert Schmieder, Mike Furlan, John S. Welch, Colin Funk, Carolyn Kelly, Mercedes Ricote and Christoph J. Binder. Their work appears in journals such as Journal of Cystic Fibrosis, PLoS ONE, The ISME Journal, American Journal of Respiratory and Critical Care Medicine and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.